Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.55 |
| ▸ | TSHR | P16473 | 8/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.53 |
| ▸ | CRHBP | P24387 | 1/20 | 0.49 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 2/20 | 0.44 |
| ▸ | HTR2C | P28335 | 2/20 | 0.44 |
| ▸ | HTR2B | P41595 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30904817 | 1.00 | TDP1 (0.55) | TDP1TSHRSMN1; SMN2CRHBPCRHR2 | |
| SCHEMBL5635692 | 0.85 | TDP1 (0.63) | TDP1TSHRSMN1; SMN2CRHBPCRHR2 | |
| SCHEMBL768285 | 0.83 | TDP1 (0.54) | TDP1TSHRSMN1; SMN2CRHBPCRHR2 | |
| SCHEMBL2910425 | 0.83 | TDP1 (0.67) | TDP1TSHRSMN1; SMN2CRHBPCRHR2 | |
| SCHEMBL29796095 | 0.83 | TDP1 (0.54) | TDP1TSHRSMN1; SMN2CRHBPCRHR2 | |
| SCHEMBL28911428 | 0.82 | TSHR (0.55) | TDP1TSHRSMN1; SMN2CRHBPCRHR2 | |
| SCHEMBL3192674 | 0.80 | TSHR (0.65) | TDP1TSHRSMN1; SMN2HSD17B10CYP3A4 | |
| SCHEMBL8335528 | 0.80 | TDP1 (0.52) | TDP1TSHRSMN1; SMN2CRHBPCRHR2 | |
| SCHEMBL10485141 | 0.80 | TDP1 (0.52) | TDP1TSHRSMN1; SMN2HSD17B10CYP3A4 | |
| SCHEMBL27935955 | 0.80 | TDP1 (0.52) | TDP1TSHRSMN1; SMN2CRHBPCRHR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118005017-B | Preparation and application of bamboo activated carbon capable of serving as catalyst carrier | 浙江佶竹生物科技有限公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-118005017-A | Preparation and application of bamboo activated carbon capable of serving as catalyst carrier | 浙江佶竹生物科技有限公司 | 2024-05-10 | — | — | CN | disclosed |
| CN-102171190-A | Insecticidal benzenedicarboxamide derivative | BAYER CROPSCIENCE AG | 2011-08-31 | — | — | CN | disclosed |
| US-20110184188-A1 | Insecticidal Benzenedicarboxamide Derivative | BAYER CROPSCIENCE AG (DE) | 2011-07-28 | — | — | US | disclosed |
| EP-2318374-A2 | INSECTICIDAL BENZENEDICARBOXAMIDE DERIVATIVE | Bayer CropScience AG (DE) | 2011-05-11 | — | — | EP | disclosed |
| CN-101679299-A | Nicotinic acid derivatives as modulators of metabotropic glutamate receptor-5 | NOVARTIS AG | 2010-03-24 | — | — | CN | disclosed |
| WO-2010012442-A2 | INSECTICIDAL BENZENEDICARBOXAMIDE DERIVATIVE | BAYER CROPSCIENCE AG (DE) | 2010-02-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110184188-A1 | Insecticidal Benzenedicarboxamide Derivative | DDT, BRD9, BCL2A1 | TDP1 4411/4885TSHR 2047/4885SMN1; SMN2 3421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.